Search

Novartis’s move to take over UK biotech NeuTec Pharma at a large premium highlights how the so-called “superbugs” have reinvigorated pharma’s interest in antibiotics.

Carlos Moreira, co-founder and chairman of Swiss data-encryption firm WISekey, talks to Science|Business editor Richard L. Hudson on the travails of entrepreneurship.

Civo BioScreening is looking for strategic partnerships to help it take forward its novel polymer screening technology.

Innate Pharma SA has applied for an initial public offering and listing on the Euronext in Paris, to raise funds to expand its pipeline of oncology therapeutics.

The European Commission launched a nine-week internet consultation with experts and the public, soliciting views on how to improve the welfare of laboratory animals.

It may not be possible to write a rulebook on how to innovate, but there is no harm in reading attempts to do so.

Wine and biotechnology come together in yet another genome project.

The University of Manchester is launching a £10 million research centre for developing sustainable energy technologies.

IBM offers a few details of its new consultancy service for R&D management. Pity about the jargon.

European Union has voted to continue funding embryonic stem cell research after a heated debate at the European Parliament on Tuesday.

USA Today reports declining R&D budgets in the USA, albeit in, it seems, just one tech sector.

For a bunch of IT experts, the EU's IST World has come up with a baffling web site, especially when the idea is to make life easy for beginners.

Cuts in federal funding have forced UC Berkeley's RAD Lab to seek industry funding. But the money may not be enough to plug the gap.

The EU wants 25 per cent of transport energy will come from biofuels by the year 2030 – and is backing research that it will help it get there.

A spin off from ETH-Zürich has devised a new generation of detection equipment that could help in the fight against terrorism. The company is now seeking investment and possible partnerships to take the technology to a commercial level.

A team of researchers from ETH-Zürich is looking for investment for their spin-off company, XpresSys, to commercialise novel protein expression technology. The technology has the potential to revolutionise screening process for new drugs.

The future of European Union funded embryonic stem cell research hangs in the balance after a heated debate at the European Parliament on Tuesday.

It may have started from a low base, but the Indian biotech industry is hurtling past the global growth rate. And overseas companies are anxious to get in on the action.

Indian firms are training large numbers of patent agents - with their eye on the large number of companies abroad looking for cheaper patenting.

The international treaty on plant genetic resources needs a gesture of trust to repair the atmosphere of suspicion that has developed, argues Emile Frison from the International Plant Genetic Resources Institute.